PR-FAMPRIDINE IMPROVES WALKING SPEED AND QUALITY OF LIFE IN MS

被引：0
|
作者：
Ewe, Renee [1 ]
Louissaint, Hannah [2 ]
Bull, Kate [2 ]
Allen, Joanne [2 ]
Farrell, Rachel [1 ,2 ]
机构：
[1] UCL, London, England
[2] UCLH, NHNN, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2017年 / 88卷
关键词：
D O I：
10.1136/jnnp-2017-ABN.155
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PO125
引用
下载
收藏
页码：A45 / A45
页数：1
相关论文
共 50 条
  • [21] Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis
    Mathiesen, Henrik K.
    Sorensen, Per S.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 1309 - 1317
  • [22] The impact of walking impairment on work and quality of life in MS patients
    Larkin, A.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (05) : S57 - S57
  • [23] Fampridine and quality of life in individuals with multiple sclerosis
    Sagawa, Yoshimasa, Jr.
    Magnin, Eloi
    Paillot, Laura
    Moulin, Thierry
    Decavel, Pierre
    SPRINGERPLUS, 2016, 5
  • [24] Effects of PR-Fampridine on gait pattern and patient-reported outcomes: a cross-over, randomized, placebo-controlled trial
    Valet, M.
    El Sankari, S.
    Van Pesch, V.
    Boulet, S.
    Lejeune, T.
    Stoquart, G.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 66 - 67
  • [25] Walking Speed and Health‐Related Quality of Life in Multiple Sclerosis
    Christine G. Kohn
    William L. Baker
    Matthew F. Sidovar
    Craig I. Coleman
    The Patient - Patient-Centered Outcomes Research, 2014, 7 : 55 - 61
  • [26] Disability and walking speed are associated with quality of life in not active progressive
    Cree, B.
    Cutter, G.
    Wolinsky, J.
    Freedman, M.
    Comi, G.
    Giovannoni, G.
    Hartung, H. -P.
    Sedel, F.
    Lublin, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 859 - 859
  • [27] Disability and walking speed are associated with quality of life in not active progressive MS: a baseline analysis of the SPI2 study
    Cree, B.
    Cutter, G.
    Wolinsky, J.
    Freedman, M.
    Comi, G.
    Giovannoni, G.
    Hartung, H. -P.
    Sedel, F.
    Lublin, F.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 812 - 813
  • [28] Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
    Hupperts, Raymond
    Lycke, Jan
    Short, Christine
    Gasperini, Claudio
    McNeill, Manjit
    Medori, Rossella
    Tofil-Kaluza, Agata
    Hovenden, Maria
    Mehta, Lahar R.
    Elkins, Jacob
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (02) : 212 - 221
  • [29] Walking speed as a predictor of community mobility and quality of life after stroke
    Grau-Pellicer, Montserrat
    Chamarro-Lusar, Andres
    Medina-Casanovas, Josep
    Serda Ferrer, Bernat-Carles
    TOPICS IN STROKE REHABILITATION, 2019, 26 (05) : 349 - 358
  • [30] The effect of spasticity on the walking speed and quality of life in patients with multiple sclerosis
    Fuvesi, J.
    Sandi, D.
    Schmidt, F.
    Kirami, B.
    Horvath, K.
    Laczo, B.
    Bencsik, K.
    Kincses, Z. T.
    Fricska-Nagy, Z.
    Vecsei, L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 788 - 788
12345